StockData
P3 Health Partners Inc. logo

P3 Health Partners Inc. (PIIIW) company profile

PIIIWNasdaqServices-Health ServicesFiscal year ends December 31Also trades as PIII
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 4/30
$0.01+0.00 (+14.89%)

Close on Oct 30, 2026Market cap $29.26MP/E –Yield –

About P3 Health Partners

Services-Health Services, SIC 8000

P3 Health Partners Inc. is a patient-centered, physician-led population health management company focused on delivering value-based care within the Medicare Advantage market. The organization operates primarily through an affiliate model that contracts directly with independent primary care physicians and physician groups, augmented by employed primary care physicians, operated clinics, and wellness centers. Its core offerings include delegated care services such as network management, credentialing, utilization management, and claims processing, alongside its proprietary P3 Technology/Health Hub platform featuring the Provider Portal, P3 Care Connect, and Analytic Management Tools. The company serves Medicare beneficiaries and partners with Medicare Advantage health plans under capitated per-member-per-month arrangements.

As of December 31, 2025, the company's network comprises 2,400 contracted primary care physicians and approximately 320 full-time employees. Its current geographic footprint spans markets across Arizona, California, Nevada, and Oregon. The provided text does not identify the location of the company's headquarters.

Summary of the business section of P3 Health Partners's latest annual report, written by StockData.

Company profile

Company

Legal name
P3 Health Partners Inc.
Founded
2020
Headquarters
Chicago, IL
Address
2045 W Grand Ave Ste B, Pmb # 82152 60612-1577
Phone
(312) 822-8897
Website
p3hp.org
Employees
320, Dec 31, 2025
Industry
Services-Health Services
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
BDO USA, P.C., Las Vegas, Nevada

Stock & identifiers

Ticker
PIIIW
Other tickers
PIII
Exchange
Nasdaq
IPO date
Feb 11, 2021
Shares outstanding
7M, Aug 3, 2026
Public float
$11.20M, Jun 30, 2024
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-50 reverse, Apr 14, 2025
SEC CIK
1832511
CUSIP
744413113
ISIN
US7444131137
FIGI
BBG00Z19LPM8
EIN
85-2992794

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Leif Elliott PedersenChief Financial Officer–
Jeffrey G. ParkDirector6,331
Gregory D. WassonDirector23,523
Mark ThiererDirector21,182
Thomas Edmunds PriceDirector6,331
Gregory N. KazarianDirector6,331
Lawrence B. LeisureDirector6,331
Mary A. TolanDirector6,331

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$750.00K-$1.09M$530.83K$4–
FY2024$10.75M$4.36M$653.95K$12–
FY2023$1.37M$1.37M$1.60M$77–
FY2022$7.10M$7.10M$2.83M$26–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryOtherTotalvs. prior year
Aric Coffman
Chief Executive Officer and President
$750.00K–$750.00K-92%
Amir Bacchus
Chief Medical Officer
$600.00K–$600.00K0%
Leif Pedersen
Chief Financial Officer
$440.00K$21.66K$461.66K-32%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Feb 11, 2021
Offer price
$10.00
Securities offered
27,500,000
Gross proceeds
$275.00M
Exchange
Nasdaq
Lock-up ends (est.)
Aug 10, 2021

“Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one-third of one redeemable warrant.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had approximately 320 full-time employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
May 26, 2026Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 15, 2026Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Nov 28, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 20, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 12, 2024Late filingNotification of late filing
Mar 17, 2023Late filingNotification of late filing
Oct 4, 2022Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 19, 2022Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 16, 2022Late filingNotification of late filing
May 24, 2022Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 17, 2022Late filingNotification of late filing
Mar 31, 2022Late filingNotification of late filing
Dec 9, 2021Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Dec 9, 2021Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 9, 2021Auditor changeChange in certifying accountant (8-K Item 4.01)
Dec 3, 2021Name changeName changed from Foresight Acquisition Corp. to P3 Health Partners Inc.
Dec 3, 2021DelistingNotice of delisting from exchange (Form 25)
Nov 15, 2021Late filingNotification of late filing
Oct 28, 2021Merger voteDefinitive merger proxy statement
Aug 17, 2021Late filingNotification of late filing
May 18, 2021Late filingNotification of late filing
Apr 1, 2021Late filingNotification of late filing
Feb 11, 2021IPOInitial public offering priced (424B4 prospectus)
Feb 8, 2021ListingRegistration of securities on an exchange (Form 8-A)